Qunzi Zhang

681 total citations
20 papers, 488 citations indexed

About

Qunzi Zhang is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Qunzi Zhang has authored 20 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 8 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Qunzi Zhang's work include Chronic Kidney Disease and Diabetes (6 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Parathyroid Disorders and Treatments (3 papers). Qunzi Zhang is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Parathyroid Disorders and Treatments (3 papers). Qunzi Zhang collaborates with scholars based in China, Australia and United States. Qunzi Zhang's co-authors include Niansong Wang, Ying Fan, Jiejun Wen, Li He, Yang Dong, Tanqi Lou, Zengchun Ye, Ze Li, Xinxin Ma and Ting Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Qunzi Zhang

19 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qunzi Zhang China 12 196 135 77 75 58 20 488
Yanlin Yu China 11 242 1.2× 187 1.4× 36 0.5× 60 0.8× 57 1.0× 15 550
Anne-Roos S. Frenay Netherlands 12 97 0.5× 125 0.9× 99 1.3× 58 0.8× 32 0.6× 22 538
Tae‐Sun Ha South Korea 15 217 1.1× 205 1.5× 60 0.8× 112 1.5× 49 0.8× 47 592
Liping Xiong China 9 199 1.0× 159 1.2× 51 0.7× 59 0.8× 121 2.1× 29 528
Letian Yang China 13 173 0.9× 185 1.4× 54 0.7× 76 1.0× 41 0.7× 33 535
Carla Ferri Spain 14 322 1.6× 166 1.2× 68 0.9× 110 1.5× 101 1.7× 33 691
Yukiko Kanetsuna Japan 9 185 0.9× 165 1.2× 49 0.6× 126 1.7× 57 1.0× 28 550
Hiroyuki Kadoya Japan 15 213 1.1× 169 1.3× 40 0.5× 95 1.3× 39 0.7× 34 550
Mümtaz Takır Türkiye 13 222 1.1× 121 0.9× 73 0.9× 129 1.7× 147 2.5× 40 644

Countries citing papers authored by Qunzi Zhang

Since Specialization
Citations

This map shows the geographic impact of Qunzi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunzi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunzi Zhang more than expected).

Fields of papers citing papers by Qunzi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunzi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunzi Zhang. The network helps show where Qunzi Zhang may publish in the future.

Co-authorship network of co-authors of Qunzi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Qunzi Zhang. A scholar is included among the top collaborators of Qunzi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunzi Zhang. Qunzi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Fei, Qunzi Zhang, Junjie Jia, et al.. (2025). The Noncanonical Wnt5a–Ca2+ Pathway Mediates Mitochondrial Dysfunction in the Progression of Diabetic Nephropathy via the Mitochondrial Calcium Uniporter. Journal of Cellular and Molecular Medicine. 29(4). e70422–e70422.
2.
He, Li, Qunzi Zhang, Xiaohua Sheng, et al.. (2025). Loss of ARNTL Enhances ER Stress and Apoptosis in CKD Through Disruption of NRF2 Signaling. The FASEB Journal. 39(11). e70715–e70715. 1 indexed citations
3.
Zhou, Yan, Xianan Li, Linqing Li, et al.. (2024). An open label, phase 1b/2 trial of LVGN6051 (4-1BB agonistic antibody) combined with anlotinib for refractory soft tissue sarcoma (STS).. Journal of Clinical Oncology. 42(16_suppl). 11554–11554. 1 indexed citations
4.
He, Li, Ze Li, Qunzi Zhang, et al.. (2022). Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging. Disease Models & Mechanisms. 15(7). 4 indexed citations
5.
Li, Xiaomei, Jiejun Wen, Yang Dong, et al.. (2021). Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling. Cell Death and Disease. 12(1). 92–92. 34 indexed citations
6.
Lin, Wenjun, Xianfeng Wu, Jiejun Wen, et al.. (2021). Nicotinamide retains Klotho expression and ameliorates rhabdomyolysis-induced acute kidney injury. Nutrition. 91-92. 111376–111376. 12 indexed citations
7.
Dong, Yang, Jianyong Yin, Teng Chen, et al.. (2021). Dl-3-n-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury. Biochemical and Biophysical Research Communications. 557. 166–173. 19 indexed citations
8.
Zhou, Ting, Yiyun Wang, Li Shen, et al.. (2021). Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy. SHILAP Revista de lepidopterología. 8(1). 93–102. 5 indexed citations
9.
Zhang, Qunzi, et al.. (2021). Sitagliptin ameliorates ER stress in diabetic kidney disease through upregulation of SIRT1. 1(1). 33–41. 2 indexed citations
10.
He, Li, Qunzi Zhang, Ze Li, et al.. (2020). Incorporation of Urinary Neutrophil Gelatinase-Associated Lipocalin and Computed Tomography Quantification to Predict Acute Kidney Injury and In-Hospital Death in COVID-19 Patients. SHILAP Revista de lepidopterología. 7(2). 120–130. 28 indexed citations
11.
Wang, Yiyun, Ting Zhou, Qiming Zhang, et al.. (2020). Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy. Kidney & Blood Pressure Research. 45(3). 378–390. 10 indexed citations
12.
Zhang, Qunzi, Li He, Yang Dong, et al.. (2020). Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3‐dependent mitochondrial homeostasis through SDF‐1α/CXCR4 pathway. The FASEB Journal. 34(6). 7500–7519. 25 indexed citations
13.
Dong, Yang, Qunzi Zhang, Jiejun Wen, et al.. (2019). Ischemic Duration and Frequency Determines AKI-to-CKD Progression Monitored by Dynamic Changes of Tubular Biomarkers in IRI Mice. Frontiers in Physiology. 10. 153–153. 106 indexed citations
14.
Fan, Ying, Zhengzi Yi, Vivette D. D’Agati, et al.. (2019). Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes. 68(12). 2301–2314. 100 indexed citations
16.
Zhang, Qunzi, et al.. (2018). Activation of the Nrf2-ARE Pathway Ameliorates Hyperglycemia-Mediated Mitochondrial Dysfunction in Podocytes Partly Through Sirt1. Cellular Physiology and Biochemistry. 48(1). 1–15. 27 indexed citations
17.
Wang, Cheng, Zengchun Ye, Yan Li, et al.. (2016). Prognostic Value of Reverse Dipper Blood Pressure Pattern in Chronic Kidney Disease Patients not Undergoing Dialysis: Prospective Cohort Study. Scientific Reports. 6(1). 34932–34932. 26 indexed citations
18.
Wang, Cheng, Yan Li, Jun Zhang, et al.. (2016). Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease. Journal of the American Heart Association. 5(10). 31 indexed citations
19.
Ye, Zengchun, Qunzi Zhang, Yan Li, et al.. (2016). High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease. Nutrients. 8(10). 645–645. 25 indexed citations
20.
Ye, Zengchun, Cheng Wang, Qunzi Zhang, et al.. (2016). Prevalence of Homocysteine‐Related Hypertension in Patients With Chronic Kidney Disease. Journal of Clinical Hypertension. 19(2). 151–160. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026